![]() |
市場調查報告書
商品編碼
1636691
2030 年動物生長促進劑市場預測:按產品類型、形式、牲畜、成分、應用和地區進行的全球分析Animal Growth Promoter Market Forecasts to 2030 - Global Analysis By Product Type (Antibiotics, Hormones, Enzymes, Probiotics, Prebiotics and Other Product Types), Form, Livestock, Source, Application and By Geography |
根據 Stratistics MRC 的數據,全球動物生長促進劑市場預計在 2024 年達到 196 億美元,到 2030 年將達到 290 億美元,預測期內的複合年成長率為 6.7%。
動物生長促進劑(AGP)是添加到動物飼料中以促進生長、提高飼料效率和預防疾病的物質。 AGP 包括抗生素、荷爾蒙和其他刺激生理過程的添加劑,幫助牲畜更快增加體重並改善其整體健康狀況。 AGP 通常用於農業以提高生產力,但其使用引發了人們對抗生素抗藥性和對人類健康的潛在影響的擔憂,導致許多國家加強了監管。
根據聯合國糧食及農業組織(FAO)的數據,2017年美國牲畜數量為9,370萬頭。
肉類和肉類需求不斷增加
全球對肉類和肉類的需求不斷成長,大大推動了市場的成長。隨著消費者偏好轉向富含蛋白質的飲食,對高效畜牧業生產的需求日益增加。牲畜生長促進劑擴大被用在提高生長速度、改善飼料效率和確保肉類的高品質。這種需求在新興市場尤其明顯,這些市場的可支配收入不斷增加和都市化刺激了肉類消費,進一步推動了市場擴張。
安全問題
對動物生長促進劑安全性的擔憂給市場帶來了重大挑戰。生長激素、抗生素和其他添加劑的使用引發了人們對它們可能在肉類中殘留的擔憂,對消費者的健康構成風險。這些擔憂導致監管機構加強審查。此外,輿論反彈可能會損害品牌聲譽,並引發向天然和有機替代品的轉變,對傳統生長促進劑的使用和市場成長構成挑戰。
加強抗生素使用的監管
抗生素使用的嚴格監管正在重塑該行業。出於對抗生素抗藥性和食品安全的擔憂,世界各國政府都在實施限制抗生素使用的指導方針。這導致人們轉向使用益生菌、酵素和植物來源添加劑等替代生長促進劑。因此,市場正在看到更安全的非抗生素解決方案的創新,生產商正在專注於永續的實踐,以滿足消費者對更健康、無抗生素肉類產品的需求。
高成本
動物生長促進劑成本高是市場面臨的一大挑戰。某些添加劑,如荷爾蒙、抗生素和益生菌,價格昂貴,會增加畜牧農民的生產成本並降低盈利。小型畜牧農戶將難以購買這些產品,而大公司可能會壟斷這些產品,從而導致市場集中。此外,投入成本上升可能導致肉類價上漲,影響消費需求。這些經濟壓力可能會阻礙市場成長。
新冠肺炎疫情為市場帶來了重大影響,擾亂了供應鏈並降低了生產能力。封鎖和勞動力短缺影響了生長促進劑關鍵成分的供應,從而導致延誤和價格上漲。這場疫情凸顯了糧食安全的重要性,也增加了人們對高效率畜牧養殖實務的興趣。這導致了人們轉向更永續且更具成本效益的生長促進劑。
抗生素市場預計將成為預測期內最大的市場
預計預測期內抗生素領域將佔據最大的市場佔有率。這些抗生素可以幫助動物更有效地增加體重,並減少感染疾病的機會。然而,人們對抗生素抗藥性及其對人體的潛在影響的擔憂日益加劇,導致一些國家訂定了更嚴格的規定。這種轉變正在塑造市場的未來,鼓勵採用益生菌、酵素和草藥補充劑等替代的促進生長的策略。
預計飼料添加劑領域在預測期內將出現最高複合年成長率
預計預測期內飼料添加劑部分將以最高的複合年成長率成長。這些添加劑包括維生素、礦物質、酵素、益生菌和有機酸,可提高飼料效率、支持消化並增強免疫功能。作為抗生素的替代品,飼料添加劑因其在促進永續和健康的畜牧業生產中的作用而越來越受歡迎。人們對抗生素抗藥性的擔憂日益加劇,推動了對天然和安全飼料添加劑的需求,預計這將影響市場成長。
預計預測期內北美地區將佔據最大的市場佔有率。重點提高牲畜生產率和飼料效率,廣泛使用抗生素、飼料添加劑和其他促進生長技術。然而,隨著監管機構對抗生素使用的審查力度加大,以及消費者對有機和無抗生素產品的偏好日益增加,市場正在重塑。該地區對替代性的、永續的成長促進解決方案的興趣也日益濃厚。
預計亞太地區將在預測期內實現最高成長率。亞太地區收入的提高和都市化推動了肉類和乳製品需求的激增,進一步增加了對動物生長促進劑的需求,以滿足生產需求。此外,集約化農業實踐和先進技術的採用也增加了對確保更快、更有效率生產的生長促進劑的需求。
According to Stratistics MRC, the Global Animal Growth Promoter Market is accounted for $19.6 billion in 2024 and is expected to reach $29.0 billion by 2030 growing at a CAGR of 6.7% during the forecast period. An Animal Growth Promoter (AGP) is a substance added to animal feed to enhance growth, improve feed efficiency, or prevent diseases. AGPs include antibiotics, hormones, and other additives that stimulate physiological processes, leading to faster weight gain and better overall health in livestock. While they are commonly used in the farming industry to boost productivity, their use has raised concerns about antibiotic resistance and potential impacts on human health, leading to increasing regulations in many countries.
According to the Food and Agriculture Organization (FAO) of the United Nations, the U.S. had 93.7 million cattle in 2017.
Rising demand for meat and meat products
The rising demand for meat and meat products globally is significantly driving the growth of the market. As consumer preferences shift toward protein-rich diets, the need for efficient livestock production increases. Animal growth promoters are increasingly used to enhance growth rates, improve feed efficiency, and ensure the availability of high-quality meat. This demand is particularly evident in developing regions, where increasing disposable incomes and urbanization are fueling meat consumption, further boosting market expansion.
Concerns about the safety
Concerns about the safety of animal growth promoters have raised significant issues in the market. The use of growth hormones, antibiotics, and other additives has sparked fears regarding potential residue in meat products, posing health risks to consumers. These concerns are leading to increased scrutiny from regulatory bodies. Additionally, public backlash against unsafe practices may harm brand reputation, causing a shift toward natural, organic alternatives, which challenges traditional growth promoter usage and market growth.
Stricter regulations on the use of antibiotics
Stricter regulations on the use of antibiotics in the market are reshaping the industry. Governments worldwide are enforcing guidelines to limit antibiotic usage due to concerns over antimicrobial resistance and food safety. This has led to a shift towards alternative growth promoters such as probiotics, enzymes, and plant-based additives. As a result, the market is witnessing innovation in safer, non-antibiotic solutions, with producers focusing on sustainable practices to meet consumer demand for healthier, antibiotic-free meat products.
High costs
High costs of animal growth promoters are a significant challenge in the market. The expensive nature of certain additives, such as hormones, antibiotics, and probiotics, increases production costs for livestock farmers, potentially reducing their profitability. Smaller-scale producers may struggle to afford these products, leading to market concentration as larger players dominate. Additionally, rising input costs could lead to higher meat prices, affecting consumer demand. These financial pressures can hinder market growth.
The COVID-19 pandemic significantly impacted the market, disrupting supply chains and reducing production capacity. Lockdowns and labor shortages affected the availability of key ingredients for growth promoters, leading to delays and price hikes. The pandemic highlighted the importance of food security, prompting increased interest in efficient livestock farming practices. This led to a shift towards more sustainable and cost-effective growth promoter solutions.
The antibiotics segment is expected to be the largest during the forecast period
The antibiotics segment is anticipated to account for the largest market share during the projection period. These antibiotics help animals reach market weight more efficiently and reduce the likelihood of infections. However, growing concerns about antibiotic resistance and its potential effects on human health have led to stricter regulations in several countries. This shift is encouraging the adoption of alternative growth-promoting strategies, such as probiotics, enzymes, and herbal supplements, shaping the future of the market.
The feed additives segment is expected to have the highest CAGR during the forecast period
The feed additives segment is expected to have the highest CAGR during the extrapolated period. These additives include vitamins, minerals, enzymes, probiotics, and organic acids that improve feed efficiency, support digestion, and boost immune function. As an alternative to antibiotics, feed additives are gaining popularity due to their role in promoting sustainable and healthier animal production. With increasing concerns about antibiotic resistance, demand for natural and safe feed additives is expected to rise, influencing the market's growth.
North America region is anticipated to account for the largest market share during the forecast period. With a strong focus on improving livestock productivity and feed efficiency, antibiotics, feed additives, and other growth-promoting technologies are widely used. However, increasing regulatory scrutiny on antibiotic use, along with rising consumer preference for organic and antibiotic-free products, is reshaping the market. The region is also witnessing growing interest in sustainable and alternative growth promotion solutions.
Asia Pacific is expected to register the highest growth rate over the forecast period. Increased incomes and urbanization in Asia Pacific have contributed to a surge in the demand for meat and dairy products, further driving the need for animal growth promoters to meet production requirements. Additionally, the adoption of intensive farming methods and advanced technologies has contributed to the demand for growth promoters to ensure faster and more efficient production.
Key players in the market
Some of the key players in Animal Growth Promoter market include Zoetis, Bayer Animal Health, Merck Animal Health, Boehringer Ingelheim Animal Health, Cargill, Inc., BASF SE, ADM Animal Nutrition, Nutreco N.V., Evonik Industries AG, Alltech Inc., DSM Nutritional Products, Lonza Group, BioZyme Inc., Novozymes and American Vanguard Corporation.
In February 2024, Blacksmith Medicines, Inc., a global biopharmaceutical company, and Zoetis, a global animal health company, announced a collaboration, to discover and develop novel antibiotics for animal health
In July 2021, ADM has announced the launch of a customized antibiotic reduction program developed by Wisium, its premix and nutrition services business. The new program centralizes Wisium's demedication solutions across all species, such as poultry, cattle and swine, offering a holistic approach.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.